beststemcellinbangkok
Allogeneic

Umbilical Cord MSCs

Donor-derived mesenchymal stromal cells isolated from donated birth tissue.

Explore Medical Suitability

Overview

Umbilical cord MSCs are mesenchymal stromal cells isolated from donated umbilical cord tissue after childbirth.

Collection of the donated tissue does not require an invasive procedure for the treatment recipient. The cells are then isolated, cultured and prepared under laboratory-controlled conditions.

The term 'umbilical cord MSCs' can refer to cells obtained from different anatomical parts of the cord, so patients should ask the provider to identify the exact tissue source.

Possible tissue sources

  • Wharton's Jelly
  • Perivascular cord tissue
  • Cord lining or membrane
  • Other defined areas of umbilical cord tissue

Umbilical cord tissue MSCs are not the same as cord-blood hematopoietic stem cells. The two products have different biological characteristics and clinical uses.

Quality information to review

  • Donor consent and eligibility
  • Maternal infectious-disease screening
  • Tissue collection and transport process
  • Cell identity markers
  • Passage number
  • Viability at administration
  • Sterility, mycoplasma and endotoxin testing
  • Batch release documentation

What patients should understand

The total number of cells does not provide a complete picture of product quality. Patients should also ask whether the stated number represents cells before freezing, after thawing or at the point of administration.

Limitations

Umbilical cord MSCs remain an active area of research. They should not be promoted as guaranteed treatments for ageing, neurological disease, autoimmune disease, joint disease or another specific condition.

Practical points before you book

  1. Step 1
    Ask for the lot COA before paying any deposit
  2. Step 2
    Confirm doctor-led suitability assessment
  3. Step 3
    Discuss realistic, case-by-case expectations

Medical suitability notice

This content is provided for general education and does not constitute medical advice. Cell-based therapies differ in source, processing, regulatory status and supporting evidence. Suitability must be determined by a qualified medical professional after individual assessment. Results cannot be guaranteed.

Not sure if this fits your case?

Send your medical documents to our Bangkok coordination team for a doctor-led review.

Explore Medical Suitability

Related educational pages

Continue with closely related topics from this guide.

Autologous
Autologous Stem Cells
Autologous stem cells are collected from the patient's own body, commonly from bone marrow, adipose tissue or peripheral blood. Because the cells come from the same person, donor compatibility is not required. Collection procedures, processing time and suitability vary depending on the selected cell source.
Allogeneic
Allogeneic Stem Cells
Allogeneic stem cells are obtained from a screened donor rather than from the patient. Potential sources may include umbilical cord tissue, Wharton's Jelly, placenta, amniotic tissue or cord blood. Donor screening, laboratory processing and product quality documentation should be reviewed before treatment.
Allogeneic
Wharton's Jelly MSCs
Wharton's Jelly is the connective tissue surrounding the blood vessels inside the umbilical cord. MSCs isolated from this tissue are donor-derived and are used in some physician-supervised regenerative programmes. Important considerations include donor eligibility, sterility testing, cell identity, viability and manufacturing standards.
← Back to all stem cell types